Literature DB >> 20599927

The collagen-breakdown product N-acetyl-Proline-Glycine-Proline (N-alpha-PGP) does not interact directly with human CXCR1 and CXCR2.

Petra de Kruijf1, Herman D Lim, Saskia A Overbeek, Guido J R Zaman, Aletta D Kraneveld, Gert Folkerts, Rob Leurs, Martine J Smit.   

Abstract

Neutrophils transmigrate from the blood into inflamed tissue via the interaction of chemokines produced in this tissue with chemokine receptors, such as CXCR1 and CXCR2, that are expressed on the membranes of neutrophils. Subsequently, activation of neutrophils will in turn lead to increased tissue damage and thereby enhanced clinical symptoms of inflammatory diseases like chronic obstructive pulmonary disease, inflammatory bowel disease and psoriasis. Besides chemokines, also the collagen-breakdown product N-acetyl-Proline-Glycine-Proline (N-alpha-PGP) attracts neutrophils. In a recent article (Weathington et al., 2006) it was suggested that N-alpha-PGP exerts its effect via CXCR1 and CXCR2. In this study, we show that N-alpha-PGP, in contrast to CXCL8, does not directly activate or interact with CXCR1 or CXCR2. N-alpha-PGP was not able to displace the radioligand [(125)I]CXCL8 from CXCR1 and CXCR2 expressing HEK293T cells or neutrophils. In addition, N-alpha-PGP did not displace the radioligand [(3)H]-SB265610, a CXCR2 antagonist, from CXCR2 expressing cells. Furthermore, N-alpha-PGP was not able to activate G protein signalling in cells expressing CXCR1 and CXCR2. N-alpha-PGP was also not able to recruit beta-arrestin2, an intracellular scaffolding protein involved in G protein-independent signalling, in cells expressing CXCR2. These studies indicate that N-alpha-PGP is not a ligand of CXCR1 or CXCR2. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599927     DOI: 10.1016/j.ejphar.2010.06.017

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

Review 1.  The matrikine PGP as a potential biomarker in COPD.

Authors:  Mojtaba Abdul Roda; Amanda M Fernstrand; Frank A Redegeld; J Edwin Blalock; Amit Gaggar; Gert Folkerts
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-04-10       Impact factor: 5.464

2.  N-acetylated Proline-Glycine-Proline induced G-protein dependent chemotaxis of neutrophils is independent of CXCL8 release.

Authors:  Saskia A Overbeek; Paul A J Henricks; Anja I Srienc; Pim J Koelink; Petra de Kruijf; Herman D Lim; Martine J Smit; Guido J R Zaman; Johan Garssen; Frans P Nijkamp; Aletta D Kraneveld; Gert Folkerts
Journal:  Eur J Pharmacol       Date:  2011-03-31       Impact factor: 4.432

3.  A CXCL8 receptor antagonist based on the structure of N-acetyl-proline-glycine-proline.

Authors:  Patricia L Jackson; Brett D Noerager; Michael J Jablonsky; Matthew T Hardison; Bryan D Cox; James C Patterson; Boopathy Dhanapal; J Edwin Blalock; Donald D Muccio
Journal:  Eur J Pharmacol       Date:  2011-03-31       Impact factor: 4.432

4.  Extracellular matrix-derived tripeptide proline-glycine-proline inhibits keratinocyte proliferation and migration.

Authors:  Yiwei Ma; Kyle Kleinbeck; W John Kao
Journal:  Wound Repair Regen       Date:  2011-10-12       Impact factor: 3.617

5.  A self-propagating matrix metalloprotease-9 (MMP-9) dependent cycle of chronic neutrophilic inflammation.

Authors:  Xin Xu; Patricia L Jackson; Scott Tanner; Matthew T Hardison; Mojtaba Abdul Roda; James Edwin Blalock; Amit Gaggar
Journal:  PLoS One       Date:  2011-01-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.